Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity
about
The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea.Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots.Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy.Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study.Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrationsThe association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South AfricaHigh prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT)Bone loss after bariatric surgery: causes, consequences, and management.Bone Remodeling and Energy Metabolism: New Perspectives.Glycerol Production from Glucose and Fructose by 3T3-L1 Cells: A Mechanism of Adipocyte Defense from Excess Substrate.Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?Physical activity may be a potent regulator of bone turnover biomarkers in healthy girls during preadolescence.Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review.Nontraditional manifestations of primary hyperparathyroidism.The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetesSerum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010.Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis).Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension.FGF-23 and secondary hyperparathyroidism in chronic kidney disease.Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines.Vitamin D alteration associated with obesity and bariatric surgery.Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans.Hormonal and systemic regulation of sclerostin.Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly.Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis.Higher circulating parathormone is associated with smaller and weaker bones in obese children.Visceral adiposity is a predictor of parathyroid hormone levels in healthy adults.Serum leptin and skeletal differences between obese and non-obese patients with chronic obstructive pulmonary disease.Is There Any Relationship between Plasma 25-Hydroxyvitamin D₃, Adipokine Profiles and Excessive Body Weight in Type 2 Diabetic Patients?The Effect of a Muscle Weight-Bearing and Aerobic Exercise Program on the Body Composition, Muscular Strength, Biochemical Markers, and Bone Mass of Obese Patients Who Have Undergone Gastric Bypass Surgery.Vitamin D levels in a paediatric population of normal weight and obese subjects.Leptin regulates disc cartilage endplate degeneration and ossification through activation of the MAPK-ERK signalling pathway in vivo and in vitro.The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.Predictive Factors of Secondary Normocalcemic Hyperparathyroidism after Roux-en-Y Gastric Bypass.Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men.Markers of Bone Metabolism in Obese Individuals Undergoing Laparoscopic Sleeve Gastrectomy.
P2860
Q30234616-AF4FB707-F8D9-4F5E-8530-3BA372A0534EQ33570171-1259B64C-CEB5-4A07-902C-AD707CD9BADEQ33925973-29E00502-8EDF-4C85-8A86-9900F5BA8CD2Q33999013-CE65FF1F-D59D-40FD-8C73-122A205273A0Q34255342-23C7C646-E38F-425D-B2DE-CE7261F948DBQ34334299-6D81D35D-15CE-439D-9051-056C99522578Q34650666-4D5F2F7D-5F55-478B-831D-31810B0E396DQ34676274-9A87A01C-356D-46E5-90A4-A67AFA728FFBQ35556238-06FCC5C8-1E2D-413E-9B06-0B274B9593B7Q35743594-A4263805-8B98-46F8-917A-63CEE937CCBBQ35755044-E96B0875-60EB-424F-9DB0-C5B2B996D4F9Q35794852-6D1CC037-E1BC-42FF-B461-5B9EC6F82122Q35967442-2241CEAB-8FB5-445E-BD5C-BF7FD5CF880FQ36190921-DF8BCE00-FF37-4722-BD33-4451E73CA581Q36301066-A1EB4D40-E0D4-40A9-94E4-B50D11A730E5Q36587833-1357293D-ADA1-465B-A88C-DCDCF77B8D92Q36609595-8D6DED3D-D1AF-456D-8A97-0BFFAB6328F5Q36820702-68109EF1-D889-4CD3-9FCD-BF2E3A8EFB75Q37671206-3600D5DF-2387-4A9C-9DB1-BBCF789EB553Q37722933-995D9E70-5673-45A4-BCFA-8604A06A0162Q38121133-5575FDAC-09D9-4B9D-9712-17C174636E8AQ38123396-A752765A-ECE6-4091-B402-731465F802FBQ38625798-1410CB0E-6038-48AE-8702-D56E8F3DC5D8Q39012131-C03B9810-CA4F-4977-8242-92D04A9ED418Q39018695-34C116E2-6B7B-4194-9AD8-779AF3082AC0Q39037907-5DE3AAE4-7564-4F8E-8B8F-5991CFA56205Q41305100-69FB0323-8138-4B05-B84C-8D9D0099AAA7Q44834439-C80065DE-81D0-4D3A-9154-C4EF7DEC4B6EQ45324535-92BDAFD0-E635-4DC1-88A8-BB5883B4A023Q45340912-609D0C46-4ACE-45D1-8C9E-D55DB72D3806Q46461611-E9C7245F-FBE7-4C28-8572-F3AB16A25AAEQ47163438-9772BB18-53C4-4C0D-9CB5-254F5A1C5756Q47172465-6481A2D7-4A96-495E-A870-5ADE39328BD4Q47229371-345C3890-F2C6-40FE-8AC0-CB2F35DEACD0Q47581707-F41FF765-5FF7-48CC-8767-1F198B73C380Q48160398-DC382367-0526-4B3E-8106-20ED85A93981Q51161134-E87F0A1F-B717-4417-A8AA-83500B87863DQ52564608-A91DE927-58C4-4822-8F37-F7DD27B81DF6Q53610476-0880AFB7-5074-412A-8B40-8424BB68850BQ53663111-918D5484-B0F8-4D15-887F-7AA7B1DCB6B0
P2860
Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@ast
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@en
type
label
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@ast
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@en
prefLabel
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@ast
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@en
P2093
P2860
P356
P1476
Serum leptin, parathyroid horm ...... ostin relationships in obesity
@en
P2093
Anthony Acton
Brenda M Cacucci
Christine E Gupta
Elizabeth Grethen
Kathleen M Hill
Munro Peacock
Robert V Considine
RoseMarie Jones
P2860
P304
P356
10.1210/JC.2011-2280
P407
P577
2012-02-22T00:00:00Z